UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $74.38 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,972,514 shares of the pharmacy operator's stock after purchasing an additional 378,039 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.92% of Walgreens Boots Alliance worth $74,384,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. Swedbank AB increased its holdings in Walgreens Boots Alliance by 45.3% in the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after buying an additional 185,762 shares during the last quarter. Merit Financial Group LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $326,000. Orca Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $322,000. Raymond James Financial Inc. acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $9,685,000. Finally, Manning & Napier Advisors LLC lifted its stake in Walgreens Boots Alliance by 28.1% during the fourth quarter. Manning & Napier Advisors LLC now owns 384,320 shares of the pharmacy operator's stock worth $3,586,000 after purchasing an additional 84,320 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on WBA. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of "Hold" and a consensus price target of $10.59.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the stock in a transaction dated Sunday, April 27th. The shares were bought at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Price Performance

WBA traded down $0.02 on Wednesday, reaching $11.19. The company had a trading volume of 8,657,737 shares, compared to its average volume of 20,868,608. The company has a market capitalization of $9.68 billion, a P/E ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.77. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average of $11.03 and a 200-day moving average of $10.45. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $16.34.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same period last year, the firm posted $1.20 earnings per share. The business's revenue was up 4.1% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.